期刊文献+

HPLC-MS/MS法测定人血清中伏硫西汀的浓度 被引量:4

Determination of vortioxetine in human serum by HPLC-MS/MS
下载PDF
导出
摘要 目的采用高效液相色谱-串联质谱法(HPLC-MS/MS)建立快速测定人血清中伏硫西汀质量浓度的方法。方法以乙腈为沉淀剂,经蛋白沉淀法处理,进高效液相串联质谱系统(HPLC-MS/MS)分析,色谱柱:Shim-pack VP-ODS柱(2.0 mm×150 mm,5μm),流动相:甲醇-5 mmoL/L甲酸铵缓冲溶液(体积比75∶25),流速:0.4 mL/min,柱温:35℃,进样量:1μL,采用电喷雾离子源、多反应监测模式,定量分析离子对为m/z 299.15→m/z 150.10(伏硫西汀)、m/z 307.25→m/z 153.10(伏硫西汀-D8)。结果伏硫西汀在2~200 ng/mL质量浓度范围内线性关系良好,伏硫西汀批间和批内精密度在0.83%~4.35%之间,准确度在95.48%~103.53%之间,提取回收率在91.93%~97.26%之间。血清质控样品在室温放置24 h、-70℃冻存7 d及14 d、冻融3次后稳定性均在85%~115%之间。结论建立的快速测定人血清中伏硫西汀质量浓度的方法处理简便、灵敏度高、专属性强、检测时间短,适用于临床伏硫西汀的血药浓度监测及药动学研究。 Objective To establish a rapid method for the determination of Vortioxetine in human serum by high performance liquid chromatography-tandem mass spectrometry(HPLC-MS/MS).Methods The serum was extracted by protein precipitation with acetonitrile as precipitant.The separation was performed on the Shim-pack VP-ODS(2.0 mm×150 mm,5μm)with multiple reaction monitoring(MRM),and methanol:5 mmol/L ammonium formate(75:25)as mobile phase.The flow rate was 0.4 mL/min,the column temperature was 35℃,and the sample injection volume was 1μL.Electrospray ionization(ESI)was used for acquisition and detection in multi reaction monitoring mode.The transitions for quantifying were m/z 299.15→m/z 150.10(Vortioxetine),m/z 307.25→m/z 153.10(Vortioxetine-D8).Results The linear range was 2-200 ng/mL for Vortioxetine.The within-run and between-run precisions were within a range of 0.83%~4.35%,the accuracy was varied between 95.48%~103.53%and the extraction recovery was ranged from 91.93%to 97.26%.The stability under different conditions(24 h at room temperature;7 days and 14 days at-70℃;three freeze-thaw cycles)was ranged from 85%to 115%.Conclusion The rapid,simple,sensitive and specific method was established for determination of Vortioxetine,which is suitable for clinical blood concentration monitoring and pharmacokinetic study of Vortioxetine.
作者 于志军 吴海根 林述胜 徐丽莉 YU Zhijun;WU Haigen;LIN Shusheng;XU Lili(Wuzhongpei Memorial Hospital of Shunde,Foshan 528300,China)
出处 《广东药科大学学报》 CAS 2020年第2期191-194,共4页 Journal of Guangdong Pharmaceutical University
关键词 伏硫西汀 高效液相色谱串联质谱 药物监测 抑郁药物 药动学 Vortioxetine HPLC-MS/MS therapeutic drug monitoring depressive drugs pharmacokinetics
  • 相关文献

参考文献7

二级参考文献49

  • 1何学军,任真,王娟,刘晶,杜宇,乔红群.RP-HPLC测定阿戈美拉汀原料药的含量[J].华西药学杂志,2010,25(2):204-205. 被引量:9
  • 2刘治军,傅得兴,孙春华,迟家敏,陈乃宏.抗抑郁药物相关的药物相互作用[J].中国药学杂志,2007,42(6):409-414. 被引量:16
  • 3KASPER S,HAMON M.Beyond the monoaminergic hypothesis:agomelatine,a new antidepressant with an innovative mechanism of action[J].World J Biol Psychiatry,2009,10(2):117-126.
  • 4de BODINAT C,GUARDIOLA-LEMAITRE B,MOCAER E,et al.Agomelatine,the first melatonergic antidepressant:discovery,characterization and development[J].Nat Rev Drug Discov,2010,9(8):628-642.
  • 5MILLAN M J,GOBERT A,LEJEUNE F,et al.The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2C receptors,blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways[J].J Pharmacol Exp Ther,2003,306(3):954-964.
  • 6PATIL S R,NERURKAR K K,KALAMKAR A M,et al.Validated LC-MS/MS method for quantification of agomelatine in human plasma and its application in a pharmacokinetic study[J].J Mass Spectrom,2012,47(1):23-28.
  • 7Sartorius N. Comorbidity of mental and physical disorders : a main challenge to medicine in the 21st century [ J]. Psychiatr Danub, 2013, 25 (Suppl. 1 ) :S4 -S5.
  • 8Gibb A, Deeks DE. Vortioxetine: First global approval[J]. Drugs, 2014, 74 : 135 - 145.
  • 9FDA. Brintellix (vortioxetine) tablets [ EB/OL ]. http ://www. rxlist. corrr/bHntellix - drug. btm, 2014 - 09 - 17.
  • 10Haggstrom L, Nielsen RZ, Danehenko N ,et al. A randomised, double - blind, study of vortioxetine versus agomelatine in adults with major depressive disorder (MDD) with inadequate response to SSRI/SNRI treatment [ J ]. Eur Neuropsychopharmacol , 2013,2 (Suppl.): S412.

共引文献34

同被引文献14

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部